製 品 安 全 デ ー タ シ ー ト（MSDS）
Contents
1. 715 lke 11 GHS LD50 3 500 mg kg CaPSAR 1993 4 300 mg kg 1 2002 5 LD50 gt 4 350 mg kg IUCLID 20002. 3 a aa 1330 20 7 3 3 100 41 4 3 28 1 0 10 1333 86 4 5 5222 0 1 lt 1 0 7631 86 9 1 548 0 1 1 0 108 88 3 3 2 PRTR PRTR 1 53 7 4 1 80 42 o 57 2 18 2 9 70 7 4 130 1 10 136 42 407 0 1 1 560 1 10 312
3. 15
4. 6
5. shift in rib profile time of testes descent Da Silva et al 1991 50 100 ppm 200 400 ppm 500 800 ppm CERI 96 4 1997 EU RAR No 30 2003
6. PATTY 4th 1994 Magnusson Kligman maximization test EHC 196 1997 DFGOT vol 16 2001 EHC 196 1997 DFGOT vol 16 2001 PATTY 4th 1994 EHC 196 1997 ACGIH 7th 2001 DFGOT vol 16 2001 PATTY 4th 1994
7. JACA 15 15
8. ICSC J 1995 0 74 mm3 s 25C 1 915 ike LD50 6200mg kg EHC 196 1997 ACGIH 7th 2001 DFGOT vol 16 2001 PATTY 4th 1994 9100mg kg EHC 196 1997 PATTY 4th 1994 12900mg kg EHC 196 1997 DFGOT vol 16 2001 PATTY 4th 1994 13000mg kg EHC 196 1997 ACGIH 7th 2001 PATTY 4th 1994 7939mg kg lt EHC 196 1997 1400mg kg DFGOT vol 16 2001 5 LD50 15800mg kg DFGOT vo
9. in vivo DNA hprt mutation DFGOTvol 18 2002 in vitro IARC 2B 2 B DFGOTvol 18 2002 1 DFGOTvol 18 2002 1 LD50 2 600 5 500 5 580 5 900 6 400 7 000 7 530 mg kg EU RAR No 30 2003 LD50 4 800 mg kg 5
10. 5 15 Ne 8 1 2005 50ppm 217mg m3 2006 50ppm 217mg m3 ACGIH 2006 TLV TWA 100ppm A3 BEI TLV STEL 125ppm A3jBEI 2008 2 1mg m3 4mg m3 ACGIH 2008 TLV TWA 3 5 mg m3 3 0lg ACGIH 2006 TLV T
11. 1B EHC 196 1997 DFGOT vol 16 2001 PATTY 4th 1994 EHC 196 1997 ACGIH 7th 2001 DFGOT vol 16 2001 PATTY 4th 1994 1993 ACGIH 7th 2001 DFGOT vol 16 2001 1 EHC 196 1997 PATTY 4th 1994
12. 6 4 0 C
13. EHC 196 1997 PATTY 4th 1994 3 EHC 196 1997 ACGIH BE vol 16 2001 1 10 15 ike LD50 15400 mg kg RTECS 2004 gt 3 gm kg RTECS 2004 LD50 GHS
14. CERI NITE No 62 2004 1 2002 EHC 190 1997 1 3 DFGOT Vol 15 2001 CERI NITE No 62 2004
15. 1 o m p ICSC J 2002 2 8 15 ike LD50 3 500 mg kg EHC 186 1996 4 769 mg kg ATSDR 1999 LD50 3 500 mg kg 5 LD50 15 400 mg kg ACGIH 7th 2002 GHS LC50 17 2 mg L 4 000 ppm ATSDR
16. MLAESK SIDS 2005 in vivo in vivo IARC 2000 2B ACGIH 2001 A3 2 CERI 96 41 1998 SIDS 2005 1 2002 1B CERI 96 41 1998 2 2 3
17. 3 15 lke 5
18. 3 4 15 lke 7 NG
19. LD50 12 000 mg kg ACGIH 7th 2001 LD50 14 100 mg kg EHC 52 1985 GHS LC50 4 12 5 28 1 28 8 33 mg L EU RAR No 30 2003 LC50 18 mg L 25C 1 mg m3 0 265 ppm 4 800 ppm 25 C 3 3 kPa 25C 33 000 ppm LC50 4 800 ppm 90 ppm 4 EU RAR No 30 2003 4 moderate 2 EU RAR No 30 2003
20. 1 5 2 1 000L 3 3 3 3 PRTR PRTR 3 14 15 lke 16 GHS JIS Z7252 2009 MSDS 1 JIS Z7250 2005 GHS
21. log Kow 2 73 PHYSPROP Database 2005 1 3 1 4 3 1263 I 13 15 lke 128 3 m 1 7
22. 1kg Ver 10 8 MSDS 1 1kg 4109 1 1 045 311 4701 FAX 0463 89 1330 045 311 4704 2012 7 9 4109 00 2 GHS 2 2 2A 2 1 1A 1B 1 1 2 2 GHS 1 15 lke we
23. 1970 I Priority1 6 in vivo IARC 1999 3 ACGIH 2001 A4 EPA 2005 D IRIS Toxiological review 2005 EU RAR No 30 2003 IARC 71 1999 IARC 47 1989 EHC 52 1986 ATSDR 2000 EU RAR30 2003 Ng et al 1992 the study suggests an increased risk of late spontaneous abortions associated with exposure to toluene at levels around 88 ppm range 50 150 ppm The results of this study are used as a basis for the risk characterisation of developmental toxicity in humans 1A
24. 5 GHS LD50 4 29 08 mg L 1 2002 6 700 ppm ppm CERI NITE No 62 2004 2 CERI NITE No 62 2004 moderate 2A CERI NITE No 62 2004 CaPSAR 1993 IARC
25. 0 65 mm2 s 25 C 1 12 15 lke 12 GHS 96 LC50 3 3mg L CERI NITE 2005 2 2 log Kow 3 16 PHYSPROP Database 2005 BOD 39 CERI 2005 2 96 LC50 0 4mg L CERI NITE 2006 1 SIDS 2005
26. EU RAR No 30 2003 1 3 CT CERI 96 4 1997 ATSDR 2000 SGOT EU RAR No 30 2003 1
27. 0 1 1 215 Ne 4
28. OECD test guideline 7 2B EU RAR No 30 2003 11 15 lke Ver 10 8 EHC 52 1986 EU RAR No 30 2003 IARC 71 1999 ATSDR 2000 in vivo in vivo in vivo in vivo EU
29. log Kow 3 15 24 LC50 900 73mg L EHC196 1998 1 00 x 106mg L PHYSPROP Database 2005 24 EC50 gt 5600mg L IUCLID 2000 HSDB 2004 96 EC50 3 5mg L EU RAR 2003 2 BOD 123
30. 1999 EHC 186 1996 9 000 ppm LC50 4 000 ppm 90 ppm 4 ATSDR 1999 24 mild 4 3 EHC 186 1996 2B ACGIH 7th 2002 EHC 186 1986
31. 1999 NTP DB Access on December 2005 in vivo in vivo in vivo ACGIH 2001 A4 IARC 1999 Group 3 CERI NITE No 62 2004 EHC 190 1997 IRIS 2003 0 1B 7
32. WA 50ppm 188mg m3 615 1kg 9 pH 130 140 C 22 5C 432 C 1vol 7 8vol 933 Pa 20 1 08 10
33. l 16 2001 PATTY 4th 1994 GHS LC50 8 gt 22500ppm DFGOT vol 16 2001 DFGOT vol 16 2001 24 20 4 EHC 196 1997 DFGOT vol 16 2001 PATTY 4th 1994 DFGOT vol 16 2001 2A 2B
Download Pdf Manuals
Related Search